Anselm Information collaborates with Teamwork.com – a leader in cloud project management solutions, enhancing collaborative efficiency in research and development.

Comprehensive Upgrade of Enterprise Collaboration Efficiency, Advancing Projects More Effectively.

 

As the complexity of business operations continues to rise, efficient project management has become an urgent challenge for enterprises. To meet this demand, Anselm Information becomes the first Solution Partner of Teamwork.com in Taiwan, offering advanced and convenient project management solutions for businesses.

 

Teamwork.com, a global leader in project collaboration solutions, is renowned for its outstanding performance and rich features in project management. With over a decade of focus on PLM solutions, Anselm Information recognizes the bottlenecks in traditional PLM systems’ project management modules and the inconvenience caused to users. Through this collaboration, Anselm Information will provide customers with a more comprehensive and professional project management solution, empowering enterprises to enhance collaboration efficiency and achieve efficient project advancement.

 

Key advantages of Teamwork.com project management solution include:

  • Comprehensive Project Management: Provides a robust project management platform, enabling teams to efficiently plan, collaborate, and execute tasks. It offers features such as task management, time tracking, and document sharing.
  • Intuitive User Interface: The platform’s user-friendly interface allows teams to easily adopt and use it. It provides a neat and organized workspace, enhancing productivity.
  • Customization: Allows users to customize according to their specific needs. Custom workflows, task lists, and templates can be created to adapt to different industries and work attributes.
  • Collaboration Tools: The platform offers various collaboration tools, including messaging, file sharing, and discussions, facilitating effective team communication and knowledge sharing.
  • Time Tracking: Includes built-in time tracking features, helping teams monitor their work hours and improve time management.
  • Reporting and Analysis: Users can access detailed reports and analyses to understand project progress and team performance.
  • Mobile Management: Provides mobile applications, ensuring teams stay connected and efficient while on the go.

 

The Teamwork.com project management platform not only meets daily project management needs for enterprises but also focuses on user experience, ensuring team members can easily get started and quickly engage in their work. Its rich features and intuitive interface make it suitable for project management across various industries and scales.

 

By choosing to be a Solution Partner of Teamwork.com, Anselm Information aims to focus on user needs and convenience during the new product development process. This partnership provides project managers and R&D departments with a comprehensive and efficient R&D collaboration solution, empowering enterprises to enhance collaboration efficiency and achieve successful product delivery, creating more value for customers.

 

If you have any questions or requirements regarding the Teamwork.com project management platform or collaboration, feel free to contact our sales team at sales@anselm.com.tw. We look forward to exploring more collaborative ways and achieving excellent enterprise management together!

Anselm Assists GOLDEN BIOTECHNOLOGY CORP. in Achieving E-documentation Management and Submission for CTD

As the complexity of drug development and market approval increases, meeting the requirements of various national pharmaceutical regulatory authorities becomes crucial. Leveraging years of experience in guiding the implementation of Oracle Agile PLM in the biotech and medical field, Anselm supports client, GOLDEN BIOTECHNOLOGY CORP., in utilizing Oracle Agile PLM along with Anselm’s developed ‘eCTD Suite’ to implement R&D document management, establish an R&D knowledge platform, and adhere to the Common Technical Document (CTD) framework developed by the International Council for Harmonisation (ICH). This assistance helps GOLDEN BIOTECHNOLOGY CORP. achieve:

 

Compliance with International Standards:

Adherence to international drug review standards such as the U.S. FDA, EU EMA, Taiwan TFDA, Japan PMDA, enhancing efficiency in submissions and obtaining drug certifications.

 

Rapid Generation of CTD Submission Documents:

Capability to generate CTD electronic submission templates based on M1~M5 sections required by different countries. The system efficiently generates CTD electronic submission document lists and data packages from Oracle Agile PLM, saving significant manual effort. Through system checks and assisted report outputs, it reduces the risk of errors, ensures the consistency and compliance of submitted documents, and maintains a complete record of the Serial Number change history.

 

Security and Compliance:

Oracle Agile PLM complies with the requirements of FDA 21 CFR Part 11, ensuring the confidentiality of sensitive data through rigorous permission controls. Additionally, we conduct system verification based on EU GAMP requirements during the implementation process, producing IQ/OQ/PQ documents. Combined with comprehensive R&D process change control, it fully meets the audit requirements of relevant regulations.

 

Real-time Collaboration:

Teams distributed across multiple global locations can achieve real-time collaboration, enhancing the speed of information flow.

 

Flexibility and Scalability:

The system can be adjusted according to client needs, providing scalability to address future technological and regulatory changes.

 

We understand the rigor and complexity of drug review processes. Through our solution, we offer a reliable, efficient, and compliant solution for the biopharmaceutical industry (new drugs, active pharmaceutical ingredients, generics), facilitating smooth regulatory approvals and rapid market entry worldwide. We look forward to providing optimal support for your business and jointly facing the challenges of the global biopharmaceutical industry.